🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Multiple Endocrine Neoplasia

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site📍 Tianjin Jacobio Pharmaceuticals Co., Ltd. · Tests: JAB-8263, JAB-8263 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites📍 Atlanta📍 Nashville📍 San Antonio Novartis Pharmaceuticals · Tests: GVV858, Fulvestrant, Letrozole Natural History Study of Parathyroid Disorders NCT04969926n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia NCT07571096n/a1 site📍 Guangzhou Guangdong Women and Children Hospital Acute Effects of Ketone Monoester Co-ingestion With Dietary Protein on Whole-body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Young Males. NCT07884539NA1 site📍 Montreal McGill University · Tests: Ketone Monoester + Dietary Protein (KET+PRO), Dietary Protein (PRO), Resistance Exercise Innovative Ovarian Cancer Biomarker Assays NCT07693894n/a7 sites📍 Prague📍 Prague📍 Athens National and Kapodistrian University of Athens · Tests: Investigational ovarian cancer biomarker assays Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer NCT07600268Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Stereotactic Body Radiotherapy (SBRT) with maintenance therapy, Maintenance therapy Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases NCT03093909Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Gemcitabine Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites📍 La Jolla📍 San Francisco📍 Miami Beach Faeth Therapeutics · Tests: Sapanisertib, Serabelisib, Paclitaxel Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging NCT05602376NA2 sites📍 East London📍 Cape Town Desmond Tutu HIV Foundation · Tests: U=U testing messaging scripts, U=U adherence messaging scripts Survivors Uniting for Remote Guided Exercise NCT07290309NA1 site📍 Fort Collins Colorado State University · Tests: Virtually Supervised Exercise Sessions, Asynchronous Group A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site📍 Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-8989 Radiofrequency Ablation Versus Hemithyroidectomy for Small Thyroid Cancers NCT06796348NA1 site📍 Aarhus University of Aarhus · Tests: Radiofrequency ablation alone, Surgery AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886NA1 site📍 Shanghai Guo ShiWei · Tests: AI-Assisted Non-Contrast CT for Multi-Cancer Screening Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms NCT06767813Phase 27 sites📍 Zhengzhou📍 Zhengzhou📍 Nanjing Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Phar… · Tests: TQB2868 injection, Gemcitabine injection, Albumin paclitaxel injection, Anlotinib capsules GROWing Up With Rare GENEtic Syndromes NCT04463316n/a1 site📍 Rotterdam dr. Laura C. G. de Graaff-Herder · Tests: Retrospective file studies Study and Follow-up of Multiple Endocrine Neoplasia Type 1 NCT03348501n/a1 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: survey for long-term follow-up of the disease DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT07665515Phase 110 sites📍 Cambridge📍 Edinburgh📍 Glasgow Epitopea Ltd · Tests: CryptiVax-1001 Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males NCT06542237Phase 1, Phase 21 site📍 Grafton YourChoice Therapeutics, Inc. · Tests: YCT-529 A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations NCT06835569Phase 114 sites📍 Orlando📍 Tampa📍 Boston Alterome Therapeutics, Inc. · Tests: ALTA3263, cetuximab, mFOLFOX6, Pembrolizumab, Pemetrexed + Cisplatin /Carboplatin To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers. NCT06849284n/a1 site📍 Truro Royal Cornwall Hospitals Trust Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer NCT06787612Phase 256 sites📍 Birmingham📍 La Jolla📍 Los Angeles Regeneron Pharmaceuticals · Tests: Ubamatamab, Bevacizumab, Cemiplimab, Fianlimab, PLD EUS-guided RFA for Pancreatic Neoplasms NCT03218345NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: EUS-guided RFA Evaluation of XYA02 in Patients With Advanced Solid Tumors NCT07670312Phase 1, Phase 25 sites📍 Sydney📍 Sydney📍 Melbourne XYone Therapeutics, Inc · Tests: XYA02 A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 NCT07186842Phase 1, Phase 218 sites📍 Denver📍 Orlando📍 Detroit BioNTech SE · Tests: BNT329, CA19-9-targeting monoclonal antibody
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy